These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 19321600)

  • 1. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.
    Bonnet CS; Aldred M; von Ruhland C; Harris R; Sandford R; Cheadle JP
    Hum Mol Genet; 2009 Jun; 18(12):2166-76. PubMed ID: 19321600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.
    Happé H; Leonhard WN; van der Wal A; van de Water B; Lantinga-van Leeuwen IS; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2009 Jul; 18(14):2532-42. PubMed ID: 19401297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.
    Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP
    Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSC2/PKD1 contiguous gene syndrome: a report of 2 cases with emphasis on dermatopathologic findings.
    Kacerovska D; Vrtel R; Michal M; Vanecek T; Vodicka R; Kreuzberg B; Ricarova R; Pizinger K; Danis D; Reischig T; Kazakov DV
    Am J Dermatopathol; 2009 Aug; 31(6):532-41. PubMed ID: 19590422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
    Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
    J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of PKD1 causes polycystic kidney disease.
    Thivierge C; Kurbegovic A; Couillard M; Guillaume R; Coté O; Trudel M
    Mol Cell Biol; 2006 Feb; 26(4):1538-48. PubMed ID: 16449663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
    Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis of cystic kidney diseases].
    Walz G
    Verh Dtsch Ges Pathol; 2002; 86():138-44. PubMed ID: 12647363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.
    Lee L; Sudentas P; Donohue B; Asrican K; Worku A; Walker V; Sun Y; Schmidt K; Albert MS; El-Hashemite N; Lader AS; Onda H; Zhang H; Kwiatkowski DJ; Dabora SL
    Genes Chromosomes Cancer; 2005 Mar; 42(3):213-27. PubMed ID: 15578690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.
    Ahrabi AK; Terryn S; Valenti G; Caron N; Serradeil-Le Gal C; Raufaste D; Nielsen S; Horie S; Verbavatz JM; Devuyst O
    J Am Soc Nephrol; 2007 Jun; 18(6):1740-53. PubMed ID: 17475819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome.
    Brook-Carter PT; Peral B; Ward CJ; Thompson P; Hughes J; Maheshwar MM; Nellist M; Gamble V; Harris PC; Sampson JR
    Nat Genet; 1994 Dec; 8(4):328-32. PubMed ID: 7894481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome.
    Oyazato Y; Iijima K; Emi M; Sekine T; Kamei K; Takanashi J; Nakao H; Namai Y; Nozu K; Matsuo M
    Kobe J Med Sci; 2011 Jun; 57(1):E1-10. PubMed ID: 22169896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1.
    Wang E; Hsieh-Li HM; Chiou YY; Chien YL; Ho HH; Chin HJ; Wang CK; Liang SC; Jiang ST
    J Pathol; 2010 Nov; 222(3):238-48. PubMed ID: 20814903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
    Lantinga-van Leeuwen IS; Dauwerse JG; Baelde HJ; Leonhard WN; van de Wal A; Ward CJ; Verbeek S; Deruiter MC; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2004 Dec; 13(24):3069-77. PubMed ID: 15496422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated.
    Cabrera-López C; Bullich G; Martí T; Català V; Ballarín J; Bissler JJ; Harris PC; Ars E; Torra R
    BMC Med Genet; 2015 Jun; 16():39. PubMed ID: 26077033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Hippo signalling in polycystic kidney disease.
    Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of a rapamycin analog (CCI-779) and interferon-gamma is more effective than single agents in treating a mouse model of tuberous sclerosis complex.
    Lee L; Sudentas P; Dabora SL
    Genes Chromosomes Cancer; 2006 Oct; 45(10):933-44. PubMed ID: 16845661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma.
    Wilson C; Idziaszczyk S; Parry L; Guy C; Griffiths DF; Lazda E; Bayne RA; Smith AJ; Sampson JR; Cheadle JP
    Hum Mol Genet; 2005 Jul; 14(13):1839-50. PubMed ID: 15888477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.